Silibinin inhibits prostate cancer cells- and RANKL-induced osteoclastogenesis by targeting NFATc1, NF-κB, and AP-1 activation in RAW264.7 cells
Kavitha, Chandagirikoppal V., Deep, Gagan, Gangar, Subhash C., Jain, Anil K., Agarwal, Chapla, Agarwal, RajeshVolume:
53
Langue:
english
Journal:
Molecular Carcinogenesis
DOI:
10.1002/mc.21959
Date:
March, 2014
Fichier:
PDF, 977 KB
english, 2014
File converter
Plus de résultats de recherche
More benefits 
